VENTILAZIONE A PRESSIONE POSITIVA DI UN'ORA DOPO UNA PROVA DI RESPIRAZIONE SPONTANEA CON SUPPORTO PRESSORIO: UNO STUDIO CLINICO RANDOMIZZATO
VENTILAZIONE A PRESSIONE POSITIVA DI UN'ORA DOPO UNA PROVA DI RESPIRAZIONE SPONTANEA CON SUPPORTO PRESSORIO: STUDIO CLINICO RANDOMIZZATO
This is a randomized, open, multicenter, pragmatic, adaptive clinical trial with intention-to-treat analysis. The study will compare two weaning strategies from mechanical ventilation in critically ill patients admitted to intensive care units, with more than 72 hours of mechanical ventilation and with a successful spontaneous breathing trial on pressure support. Immediately after a successful spontaneous breathing trial, eligible patients will be randomized into 2 groups that will be treated according to one of the following interventions:1) One-hour positive pressure ventilation: as soon as the success of the spontaneous breathing trial is confirmed, the patient is submitted to mechanical ventilation for 1 hour using the previous ventilatory parameters and, afterwards, extubated.2) Immediate extubation: the patient is extubated immediately after the success of the spontaneous breathing trial.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Adaptive design for sample size. The study will include up to a maximum of 4.000 patients. First interim analysis will be performed after complete data is available for the first 500 eligible patients. The Bayesian logistic regression model will be adjusted to provide posterior probabilities that will be compared with threshold values to evaluate stopping decisions. Extensive simulations were conducted to develop and understand adaptive design performance, interim analysis timing, and decision criteria. The trial may be stopped early for efficacy or futility. Secondary outcomes will be analyzed with a gatekeeping procedure to preserve overall type I error at 0.05. Thus, the assessment of statistical significance of secondary outcomes will be performed only if the preceding outcome in the hierarchy met the threshold for statistical significance. No adjustment for multiple comparisons will be applied for analyses of tertiary outcomes and subgroups. Thus, these results should be interpreted as exploratory.Secondary outcomes tested in hierarchical order will be: (1) Mechanical ventilation free days within 28 days; (2) Hospital free days within 28 days; (3) Mortality within 28 days.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Aline B Pereira
- Numero di telefono: +55 (47) 99181-8400
- Email: linibp@hotmail.com
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients aged > 18 years.
- Admitted to the intensive care unit (surgical or medical).
- With endotracheal intubation.
- Mechanical ventilation for more than 72 hours.
- Who underwent successful spontaneous breathing trial (according to the study protocol) and is considered able to be extubated.
Exclusion Criteria:
- Patients unable to obey commands.
- With non-planned extubation.
- Neuromuscular disease and cervical spinal cord injury.
- Tracheostomy.
- Contraindication for cardiopulmonary resuscitation or reintubation.
- Terminal extubation.
- Lack of informed consent.
- Previously included in the trial.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Ventilazione a pressione positiva di un'ora
|
As soon as the success of the spontaneous breathing trial is confirmed, the patient will be submitted to one-hour positive pressure ventilation using the previous ventilatory parameters and, afterwards, extubated. |
|
Comparatore attivo: Estubazione immediata
|
The patient will be extubated immediately (up to 10 minutes) after the success of the spontaneous breathing trial. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of Participants With Extubation Failure Within 7 Days
Lasso di tempo: 7 days (from randomization through Day 7 after randomization)
|
Extubation failure is defined as a composite endpoint of reintubation or death within 7 days after randomization |
7 days (from randomization through Day 7 after randomization)
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Ventilator-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)
|
Ventilator-free days are defined as the number of days alive and free from invasive mechanical ventilation from randomization through Day 28 after randomization. If a patient dies before day 28, the ventilator-free days will be counted as zero. If a patient is reintubated and returns to mechanical ventilation and later is extubated again and remains in unassisted breathing until day 28, the ventilator-free days will be counted from the end of the last period of assisted breathing until day 28. An invasive mechanical ventilation period of less than 24 hours for surgical purposes will count as 1 ventilator-free day. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from mechanical ventilation for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome. |
28 days (from randomization through Day 28 after randomization)
|
|
Hospital-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)
|
Hospital-free days are defined as the number of days alive and out of the hospital from randomization through Day 28 after randomization. If a patient dies before day 28, the hospital-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from hospital for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed through day 28 to ascertain this outcome. |
28 days (from randomization through Day 28 after randomization)
|
|
Number of Participants Who Died Within 28 Days
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)
|
All-cause mortality from randomization through day 28 |
28 days (from randomization through Day 28 after randomization)
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Ventilatory Support-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)
|
Ventilatory support-free days are defined as the number of days alive and free from any ventilatory support (invasive or noninvasive) from randomization through day 28. Any use of invasive mechanical ventilation for any duration during a calendar day will count as 1 day with ventilatory support (i.e., not free). Use of noninvasive ventilatory support (noninvasive ventilation or high-flow nasal cannula) for ≥6 hours in any calendar day will count as 1 day with ventilatory support. Participants who die before day 28 will be assigned 0 ventilatory support-free days. If reintubation occurs and the participant later achieves unassisted spontaneous breathing again, ventilatory support-free days will be counted from the end of the last assisted-breathing period through day 28, provided the participant remains alive and free from ventilatory support. |
28 days (from randomization through Day 28 after randomization)
|
|
Number of Participants With Extubation Failure Within 2 Days
Lasso di tempo: 2 days (from randomization through Day 2 after randomization)
|
Extubation failure is defined as a composite endpoint of reintubation or death within 2 days after randomization |
2 days (from randomization through Day 2 after randomization)
|
|
Number of Participants With Death or Reintubation Within 28 Days
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)
|
Composite endpoint of reintubation or death within 28 days after randomization |
28 days (from randomization through Day 28 after randomization)
|
|
Intensive Care Unit-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)
|
ICU-free days are defined as the number of days alive and out of the intensive care unit from randomization through day 28. If a patient dies before day 28, the ICU-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered as alive and free from ICU for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome. |
28 days (from randomization through Day 28 after randomization)
|
|
Number of Participants Who Died in the Hospital
Lasso di tempo: From randomization to hospital discharge, up to 90 days
|
All-cause mortality occurring from randomization until hospital discharge (death before hospital discharge) |
From randomization to hospital discharge, up to 90 days
|
|
Number of Participants Who Died in the Intensive Care Unit
Lasso di tempo: From randomization to ICU discharge, up to 90 days
|
All-cause mortality occurring from randomization until ICU discharge (death before ICU discharge) |
From randomization to ICU discharge, up to 90 days
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- GS-Wean: PSV SBT
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .